Objectives: To evaluate two enrichment broths for methicillin-resistant Staphylococcus aureus (MRSA) detection and compare results with direct plating.
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) has become a worldwide problem, causing healthcare-associated, communityassociated and pet and livestock-associated infections. 1 Infection is often preceded by colonization, 2 which heightens the importance of reliable identification of the bacteria. Active surveillance is important for the prevention of MRSA transmission and outbreaks in healthcare institutions. In endemic countries, such as Germany and the UK, pre-admission screening or risk-adapted screening is discussed, stressing the need for methods with a high positive predictive value (PPV).
In-house and commercial PCR-based methods have been recently introduced. These techniques reduce the laboratory turn-around time to a few hours, but sensitivity and specificity problems have been reported testing clinical samples. 3 Furthermore, PCR does not provide an isolate for further testing, 4 which is why culture-based identification remains necessary for molecular characterization and antibiotic susceptibility testing. For phenotypic methods, laboratories can currently choose between direct plating on non-selective agar or on chromogenic agar with or without a pre-enrichment step using either a nonselective or a semi-selective broth. A number of comparative studies have shown conflicting results and what is 'best practice' is still unclear.
To analyse the performance of a new semi-selective broth on clinical and screening samples for MRSA, we performed a multicentre study comparing six methods: (I) direct plating on chromogenic agar; (II) direct plating on both Columbia sheep blood (5%) agar (BA) and chromogenic agar; (III, IV) enrichment with # The Author 2010. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org J Antimicrob Chemother 2010; 65: 717 -720 doi:10.1093/jac/dkq001 Advance publication 3 February 2010 a non-selective enrichment broth (NB) followed by plating on BA and chromogenic agar; and (V, VI) enrichment with a semiselective broth containing cefoxitin and aztreonam followed by plating on BA and ChromID MRSA.
Materials and methods

Setting
The study was carried out by the EUREGIO MRSA-net with six German participating laboratories covering hospitals and general practitioners in the Mü nsterland area, the Ruhr district and Western Lower Saxony. We chose this area as there is a coherent collaboration of microbiological laboratories and a mean MRSA prevalence in hospitals of 1.6/100 admitted patients. 5 
Study evaluation
Screening cultures were obtained from patients at admission to hospitals on the basis of the German national recommendation for risk of MRSA carriage (http://www.egms.de/pdf/journals/dgkh/2009-4/dgkh000126. pdf). The screening was from nares, throat, perineum and wounds. The swabs were first analysed at the peripheral laboratories, replaced in the transport medium and sent to the study centre, the Institute of Hygiene, Mü nster. Microbiological identification of S. aureus was performed in each laboratory with one of three MRSA-selective media (bioMérieux, Marcy l'Étoile, France; Bio-Rad Laboratories, Marnes-la-Coquette, France; Heipha, Dr. Mü ller GmbH, Eppelheim, Germany). Species identification and susceptibility testing were performed using VITEK 2 automated systems (bioMérieux, Marcy l'Étoile, France). Methicillin resistance was confirmed by two laboratories by either mecA PCR or penicillin-binding protein 2a (PBP2a) latex agglutination test.
At the study centre, the swab was suspended in 0.5 mL of NB (Heipha Diagnostika, Eppelheim, Germany) and vortexed. Aliquots of 100 mL of this suspension were (I) streaked on ChromID MRSA agar (bioMérieux), (II) streaked on BA (Heipha Diagnostika) and ChromID MRSA, (III, IV) inoculated into NB followed by plating on BA and ChromID MRSA and (V, VI) inoculated into a semi-selective tryptic soy broth with 2.5% salt, 3.5 mg/L cefoxitin and 20 mg/L aztreonam (TSB-SSI, SSI Diagnostica, Hillerød, Denmark) followed by plating on BA and ChromID MRSA. Each of the broths was incubated overnight at 358C in ambient air. Aliquots of 100 mL of each broth were plated onto BA and ChromID MRSA and agars were further incubated at 358C overnight. Staphylococci were confirmed to be S. aureus by Staphaurex (Remel/Oxoid GmbH, Wesel, Germany), DNase production on DNase test agar (Heipha Diagnostika) and API Staph (BioMérieux). Methicillin resistance was detected by disc diffusion using 30 mg cefoxitin (Oxoid GmbH) discs in accordance with CLSI standards. Methicillin resistance was confirmed by oxacillin Etest (AB Biodisk, Solna, Sweden) on Mueller-Hinton agar with 2% salt (Heipha Diagnostika) and using the PBP2a latex agglutination test. All MRSA isolates were spa typed as described previously. 6 
Comparison with the peripheral laboratories
For all swabs with complete data available from the peripheral laboratories, results from the central laboratory were cross-checked with the results of the three peripheral laboratories.
Statistics
Sensitivities and specificities for each method were calculated using the results of cefoxitin, Etest and the PBP2a latex agglutination test as gold standard. The combined MRSA-positive rate was calculated using the combined result of all methods tested in the study centre. McNemar's test for paired samples was performed using Stata Statistical Software 8 (Stata Corporation, College Station, TX, USA).
Results
Study evaluation
In total, 1224 swabs from six laboratories were analysed: 798 swabs from screening samples; 196 samples from wounds, devices etc.; and 230 samples with unknown specimen type. In total, 263 MRSA-positive samples were identified [for details, see Table S1 , available as Supplementary data at JAC Online (http://jac.oxfordjournals.org/)].
The sensitivity of TSB-SSI and sub-plating was significantly higher compared with direct plating on ChromID MRSA (P,0.001), with direct plating on both BA and ChromID MRSA (P ¼ 0.029) and with NB and sub-plating (P¼ 0.027). Nineteen MRSA isolates (7%) were only found by direct plating, 12 (5%) only by NB and sub-plating and 27 (10%) by TSB-SSI and subplating only.
Growth of methicillin-susceptible S. aureus (MSSA) was evaluated for the MRSA-selective media to define the number of false positive samples, i.e. samples with growth of MSSA on the ChromID MRSA agar. MSSA was found on all types of media and by at least one method in 133 patient samples (10.9%).
The best overall result with the highest PPV was obtained by use of TSB-SSI in combination with ChromID MRSA (Table 1) . The use of TSB-SSI detected 18% more MRSA-positive throat samples than direct plating alone (P¼0.039) and 10% more than the use of NB (P¼0.07). For other sample types, no significant differences were observed (Table S1) .
MRSA isolates that did not grow in TSB-SSI were retested using an inoculum of 20 cfu in TSB-SSI and all isolates showed full growth.
The most frequently found spa types belonged to spa clonal complexes (CCs) CC003 (53%) and CC032 (27%); other CCs included CC004 (6%), CC002 (3%) and CC011 (3%).
Comparison with original results from the peripheral laboratories
For 997 samples, results from the peripheral laboratories were available for comparison. The peripheral laboratories detected 172 MRSA compared with 241 MRSA in the study centre with at least one of the tested methods (Table 2) . For direct plating, concordant results between peripheral laboratories and the study centre were found in 887, for NB in 879 and for TSB-SSI in 877 specimens. Interestingly, the peripheral laboratories found 34 MRSA that were not found with any of the methods in the study centre, whereas 103 MRSA were found solely by the study centre. As seen in Table 2 each of the evaluated methods detected more MRSA than was found initially at the peripheral laboratories, TSB-SSI significantly more (19%, P,0.005).
Discussion
Screening for MRSA is an important control measure to decrease transmission, decrease infection rates and reduce hospital costs. 7 It is, however, worthwhile to be critical in the choice of screening methods.
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The newly developed semi-selective TSB-SSI had a significantly higher sensitivity and PPV and more often provided a pure culture after overnight incubation (data not shown) compared with NB and the combination of chromogenic agar and BA. However, no method found .85% of the total number of MRSA. Eighteen MRSA isolates were only detected by direct plating, which was unexpected as the broths generally detected more MRSA isolates than the agars. The discrepancies in detection of single MRSA isolates might be explained by the re-use of the swabs within the study, or dilution of swab material, leading to bacterial cell loss and finally an uneven distribution of bacterial cells on the tested media. This is also supported by the fact that all MRSA isolates that were not detected by TSB-SSI in this study, grew in a subsequent in vitro examination in the TSB-SSI broth when seeded with only 20 cfu/mL. However, 103 MRSA isolates were only detected in the study centre despite re-using the swabs.
By use of TSB-SSI significantly more MRSA-positive throat samples were detected compared with direct plating and tended to be significant compared with NB, possibly because of inhibition of annex flora by the selective agents. Others have found similar results using selective broth, 8 indicating that throat carriers may be misclassified as negative using direct plating and/or non-selective broth.
A disadvantage of the enrichment strategy is the time delay introduced by this step, but, compared with NB, detection was faster with the semi-selective medium, as the 24 h culture was more often a pure culture. TSB-SSI was used during an EMRSA-15 outbreak in Denmark. Combining TSB-SSI with an in-house real-time PCR method, the laboratory time for MRSAnegative samples was reduced from 3 days to 24 h. 9 When screening large numbers of patients, broth-based enrichment has the advantage that samples from the same patient can be pooled, reducing laboratory workload. 9 Finally, enrichment could be combined with immunomagnetic separation, using antibodies against protein A.
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The most frequently found spa CCs were CC003 and CC032, known to be endemic for the study region.
5 spa CC011 was also found and belongs to multilocus sequence type ST398 known as livestock-associated MRSA, which have been described to be frequently imported into hospitals of the study region. 5 The maximum sensitivity obtained was only 85%. All isolates detected at the peripheral laboratories, but not by the study centre, grew in a later in vitro evaluation. This indicates that the low sensitivity found at the study centre was possibly due to the study design using pre-used swabs and diluting swab material. Semi-selective broth improves screening for MRSA 719 
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In conclusion, TSB-SSI broth followed by sub-plating was superior to non-selective broth and direct plating. Additionally, TSB-SSI detected more positive throat samples, indicating that the throat may be an overlooked place for MRSA carriage when non-selective broths and direct plating are used for MRSA screening.
